HIT Consultant January 13, 2025
What You Should Know:
– Caidya, a global mid-sized clinical research organization (CRO), announced today a $165 million strategic growth investment from funds managed by Rubicon Founders, a healthcare investment firm focused on building and growing transformative companies.
– The strategic investment will support Caidya’s continued expansion and its mission to accelerate the development of innovative therapies for unmet medical needs.
Fueling Growth and Strategic Acquisitions
Rubicon Founders’ investment will be instrumental in driving Caidya’s next phase of growth, enabling:
- Organic expansion: Further expanding Caidya’s global footprint and service offerings.
- Strategic acquisitions: Exploring potential acquisitions to enhance capabilities and accelerate growth.
This investment complements Caidya’s existing investors, which include leading global venture capital, private equity, and...
Today's Sponsors
Today's Sponsor